Nebido (Testosterone Undecanoate)

Testosterone undecanoate, the active ingredient in Nebido, is an androgen presented as an intramuscular injection for intramuscular use. It belongs to the hormone replacement therapy class and is used to replace deficient endogenous testosterone in adult males with hypogonadism, in cases of testosterone deficiency, and to support delayed puberty in adolescent males.

GNH USA supplies Nebido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for regulated medicines.

Nebido is an androgen used in hormone replacement therapy to address conditions caused by low testosterone. - Male hypogonadism: restores normal testosterone levels, improving symptoms such as low libido, fatigue, and muscle loss. - Testosterone deficiency: provides sustained testosterone replacement, helping to normalize hormonal balance and related clinical signs. - Delayed puberty in males: supplies exogenous testosterone to stimulate the development of secondary sexual characteristics.

Nebido may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site pain: discomfort at the injection site. - Headache: mild to moderate headache episodes. - Acne: increased skin oiliness leading to acne. - Fluid retention: mild edema, especially in lower extremities.

Serious or Rare Side Effects: - Cardiovascular events: possible increased risk of heart attack or stroke. - Liver toxicity: elevated liver enzymes or hepatitis. - Severe allergic reaction: anaphylaxis, rash, or angioedema. - Prostate abnormalities: rapid growth of existing prostate cancer.

Before initiating Nebido, clinicians should consider several safety measures. - Screen patients: assess testosterone levels and underlying conditions before initiating therapy. - Monitor hematocrit: regular blood tests to detect polycythemia. - Evaluate cardiovascular risk: consider history of heart disease before use. - Assess prostate health: screen for prostate cancer prior to treatment. - Avoid use in known hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nebido can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Anticoagulants: may increase risk of thrombosis due to erythrocytosis. - CYP3A4 inhibitors: can raise testosterone levels, increasing adverse effect risk. - Glucocorticoids: may exacerbate fluid retention and hypertension.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: testosterone can affect glucose metabolism. - Antihypertensives: possible alteration of blood pressure control. - Lipid‑lowering agents: testosterone may modify lipid profiles.